We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-13.55%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$488M
AUM Growth
-$122M
Cap. Flow
-$46M
Cap. Flow %
-9.42%
Top 10 Hldgs %
12.26%
Holding
885
New
278
Increased
177
Reduced
136
Closed
293

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$7.96M
2
MSFT icon
Microsoft
MSFT
+$6.24M
3
EL icon
Estee Lauder
EL
+$5.96M
4
CSCO icon
Cisco
CSCO
+$5.04M
5
WBA
Walgreens Boots Alliance
WBA
+$4.16M

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Consumer Discretionary 16.56%
3 Healthcare 14.16%
4 Industrials 11.69%
5 Consumer Staples 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LHX icon
176
L3Harris
LHX
$56.5B
$890K 0.18%
+6,612
New +$999K
CCL icon
177
Carnival Corporation Ltd
CCL
$37.1B
$884K 0.18%
+17,922
New +$1.03M
RL icon
178
Ralph Lauren
RL
$22.6B
$879K 0.18%
8,500
-13,100
-61% -$1.54M
HII icon
179
Huntington Ingalls Industries
HII
$11.4B
$875K 0.18%
+4,600
New +$1M
HON icon
180
Honeywell
HON
$77.9B
$873K 0.18%
7,007
+139
+2% +$19K
FIT
181
DELISTED
Fitbit, Inc. Class A common stock
FIT
$868K 0.18%
+174,600
New +$901K
RNG icon
182
RingCentral
RNG
$4.5B
$866K 0.18%
10,500
+1,400
+15% +$110K
ISRG icon
183
Intuitive Surgical
ISRG
$128B
$865K 0.18%
5,418
-300
-5% -$50.8K
BR icon
184
Broadridge
BR
$17.7B
$863K 0.18%
8,962
+4,100
+84% +$444K
PPLI
185
People Inc
PPLI
$3.15B
$860K 0.18%
26,298
+761
+3% +$25.5K
USNA icon
186
Usana Health Sciences
USNA
$412M
$860K 0.18%
7,304
-4,000
-35% -$463K
BAH icon
187
Booz Allen Hamilton
BAH
$8.59B
$850K 0.17%
18,864
-700
-4% -$34.4K
SSNC icon
188
SS&C Technologies
SSNC
$18.1B
$847K 0.17%
18,784
+2,000
+12% +$97.1K
UMPQ
189
DELISTED
Umpqua Holdings Corp
UMPQ
$846K 0.17%
+53,228
New +$1M
PSX icon
190
Phillips 66
PSX
$83.3B
$844K 0.17%
+9,800
New +$958K
BEL
191
DELISTED
Belmond Ltd.
BEL
$839K 0.17%
33,500
+16,300
+95% +$314K
SINA
192
DELISTED
Sina Corp
SINA
$837K 0.17%
+15,600
New +$964K
ZTS icon
193
Zoetis
ZTS
$32.2B
$826K 0.17%
+9,661
New +$870K
CACI icon
194
CACI
CACI
$11B
$822K 0.17%
5,704
+1,196
+27% +$204K
OLN icon
195
Olin
OLN
$2.49B
$819K 0.17%
40,731
+15,377
+61% +$328K
VCEL icon
196
Vericel Corp
VCEL
$2.31B
$811K 0.17%
+46,600
New +$697K
IPG
197
DELISTED
Interpublic Group of Companies
IPG
$809K 0.17%
39,200
-17,300
-31% -$395K
BLMN icon
198
Bloomin' Brands
BLMN
$731M
$803K 0.16%
44,908
-11,300
-20% -$223K
ACIA
199
DELISTED
Acacia Communications Inc
ACIA
$800K 0.16%
21,056
+3,456
+20% +$140K
LGND icon
200
Ligand Pharmaceuticals
LGND
$5.96B
$789K 0.16%
9,321
+2,350
+34% +$251K

Similar funds

Bayesian Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Bayesian Capital Management held 885 positions worth $488M, down 20% from $611M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bayesian Capital Management withdrew a net $46M in Q4 2018, closing 293 positions and reducing 136 holdings. Its most notable exit was Lowe's Companies, an estimated $6.56M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Nike worth $7.89M.

  • Bayesian Capital Management's largest Q4 2018 buy was Nike: 106,400 shares worth $7.89M.
  • Bayesian Capital Management added most to Microsoft in Q4 2018, an estimated $6.24M increase.
  • Bayesian Capital Management's biggest Q4 2018 reduction was lululemon athletica, cutting an estimated $6.86M.
  • Bayesian Capital Management fully exited Lowe's Companies in Q4 2018, selling an estimated $6.56M.
  • Bayesian Capital Management's ten largest holdings make up 12% of its $488M portfolio in Q4 2018.
  • Bayesian Capital Management opened 278 new positions and closed 293 in Q4 2018.
  • Bayesian Capital Management's portfolio value fell 20% quarter-over-quarter to $488M.

Based on Bayesian Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.